Barinthus Biotherapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Barinthus Biotherapeutics stock has a target of 4.00, which predicts a 566.67% increase from the current stock price of 0.6.

Price Target: $4.00 (+566.67%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$4.00	$4.00	$4.00
Change	+566.67%	+566.67%	+566.67%	+566.67%

* Price targets were last updated on Nov 17, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Barinthus Biotherapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $3 → $4	Strong Buy	Maintains	$3 → $4	+566.67%	Nov 17, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $3	Strong Buy	Reiterates	$3	+400.00%	Mar 21, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $5 → $3	Strong Buy	Maintains	$5 → $3	+400.00%	Jan 13, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+733.33%	Nov 19, 2024
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+733.33%	Nov 8, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.45

from -1.64

EPS Next Year

-1.49

from -1.45

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	268.00K	44.70M	802.00K	14.97M	-	-	-
Revenue Growth	-94.44%	16,580.22%	-98.21%	1,766.46%	-	-	-
EPS	-1.96	0.14	-1.91	-1.55	-1.64	-1.45	-1.49
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.49	-1.53
Avg	-1.45	-1.49
Low	-1.39	-1.43

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.